comparemela.com
Home
Live Updates
Siham Abdelgani - Breaking News
Pages:
Siham Abdelgani News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Empagliflozin Sheds Liver Fat in People With and Without T2D
Empagliflozin reduced liver fat content in patients with obesity and patients with type 2 diabetes.
San antonio
United states
University of texas
Siham abdelgani
Division of diabetes
University of texas health science center
Texas health science center
Liver disease
Hepatic impairment
Diabetes mellitus type 2
Iabetes mellitus type ii
Type 2 diabetes
Ype 2 dm
Empagliflozin Reduces Liver Fat Content Regardless of T2DM, Study Finds
Findings were presented at The Liver Meeting 2023 from the American Association for the Study of Liver Diseases and showed empagliflozin reduced liver fat content in both patients with T2DM and nondiabetic patients.
United states
Linkedin siham abdelgani
Siham abdelgani
University of texas at san antonio
Liver meeting
American association
Liver diseases
San antonio
Type 2 diabetes mellitus
Diabetes mellitus
Fatty liver
Fatty liver disease
Liver fat
Hepatic fat
vimarsana © 2020. All Rights Reserved.